RT Journal Article
T1 Effect of the Theta-Beta Neurofeedback Protocol as a Function of Subtype in Children Diagnosed with Attention Deficit Hyperactivity Disorder
A1 Duarte Hernández, Elimelech
A1 González Marqués, Javier
A1 Alvarado Izquierdo, Jesús María
AB Neurofeedback is a neuronal self-regulation technique that teaches people to modulate their brain frequencies using visual and auditory reinforcements presented on a computer screen. To assess the effect of neurofeedback training in children with ADHD as far as improved attention and impulse control, and analyze whether or not there are differences between the inattentive and hyperactive subtypes. Fifty children diagnosed with ADHD participated in the study: 14 comprised the control group, and 36 the experimental group (16 with the inattentive ADHD subtype, 20 with the hyperactive ADHD subtype). Attention and impulse control were assessed using the Integrated Visual Auditory CPT (IVA/CPT). Results indicated that the predominantly inattentive group showed significant differences on the Control Scale (p = .023, d = 1.31) and the Attention Scale (p < .01, d = 1.89) of the IVA/CPT; meanwhile the predominantly hyperactive group showed significant improvement on the Control Scale ( p  = .016,  d  = 1.21). The control group exhibited no significant differences on either of the two scales ( p  > .5). In terms of theta/beta ratio, no significant differences were detected ( p  = .10) between ADHD subtypes. The findings suggest that neurofeedback training using the theta/beta protocol was more effective in the predominantly inattentive subset of individuals with ADHD.
PB Cambridge University Press
SN 1138-7416
YR 2016
FD 2016
LK https://hdl.handle.net/20.500.14352/99075
UL https://hdl.handle.net/20.500.14352/99075
LA eng
NO Duarte Hernández E, González Marqués J, Alvarado JM. Effect of the Theta-Beta Neurofeedback Protocol as a Function of Subtype in Children Diagnosed with Attention Deficit Hyperactivity Disorder. The Spanish Journal of Psychology. 2016;19:E30. doi:10.1017/sjp.2016.31
DS Docta Complutense
RD 29 abr 2025